FDA Inspection 1101264 — Zhejiang Xianju Pharmaceutical Co., Ltd. (Yangfu API).
The FDA completed an inspection of Zhejiang Xianju Pharmaceutical Co., Ltd. (Yangfu API). on August 23, 2019 in Xianju. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- August 23, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Xianju (China)